BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 11559948)

  • 1. TEL/AML1 rearrangement and the prognostic significance in childhood acute lymphoblastic leukemia in Hong Kong.
    Tsang KS; Li CK; Chik KW; Shing MM; Tsoi WC; Ng MH; Lau TT; Leung Y; Yuen PM
    Am J Hematol; 2001 Oct; 68(2):91-8. PubMed ID: 11559948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of TEL/AML1 fusion transcript in childhood B-precursor acute lymphoblastic leukemia.
    Takahashi Y; Horibe K; Kiyoi H; Miyashita Y; Fukuda M; Mori H; Nozaki C; Hasegawa S; Kawabe T; Kato K; Kojima S; Matuyama T; Naoe T
    J Pediatr Hematol Oncol; 1998; 20(3):190-5. PubMed ID: 9628428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
    Seeger K; Adams HP; Buchwald D; Beyermann B; Kremens B; Niemeyer C; Ritter J; Schwabe D; Harms D; Schrappe M; Henze G
    Blood; 1998 Mar; 91(5):1716-22. PubMed ID: 9473238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of conventional cytogenetics, FISH, and RT-PCR to detect genetic changes in 70 children with ALL.
    Soszynska K; Mucha B; Debski R; Skonieczka K; Duszenko E; Koltan A; Wysocki M; Haus O
    Ann Hematol; 2008 Dec; 87(12):991-1002. PubMed ID: 18633615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.
    Borkhardt A; Cazzaniga G; Viehmann S; Valsecchi MG; Ludwig WD; Burci L; Mangioni S; Schrappe M; Riehm H; Lampert F; Basso G; Masera G; Harbott J; Biondi A
    Blood; 1997 Jul; 90(2):571-7. PubMed ID: 9226156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of common fusion transcripts in acute lymphoblastic leukemia: A report of 304 cases.
    Chopra A; Soni S; Verma D; Kumar D; Dwivedi R; Vishwanathan A; Vishwakama G; Bakhshi S; Seth R; Gogia A; Kumar L; Kumar R
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):293-8. PubMed ID: 26264145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
    Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG
    Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of TEL-AML1 transcript in acute lymphoblastic leukemia in long-term remission.
    Endo C; Oda M; Nishiuchi R; Seino Y
    Pediatr Int; 2003 Jun; 45(3):275-80. PubMed ID: 12828580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
    J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse.
    Harbott J; Viehmann S; Borkhardt A; Henze G; Lampert F
    Blood; 1997 Dec; 90(12):4933-7. PubMed ID: 9389711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular detection of TEL-AML1 transcripts as a diagnostic tool and for monitoring of minimal residual disease in B-lineage childhood acute lymphoblastic leukemia.
    Park HJ; Lee KE; Um JM; Choe SY; Chi XZ; Lee JA; Shin HY; Ahn HS; Bae SC
    Mol Cells; 2000 Feb; 10(1):90-5. PubMed ID: 10774753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse of TEL-AML1--positive acute lymphoblastic leukemia in childhood: a matched-pair analysis.
    Seeger K; von Stackelberg A; Taube T; Buchwald D; Körner G; Suttorp M; Dörffel W; Tausch W; Henze G
    J Clin Oncol; 2001 Jul; 19(13):3188-93. PubMed ID: 11432885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.
    Pine SR; Wiemels JL; Jayabose S; Sandoval C
    Leuk Res; 2003 Feb; 27(2):155-64. PubMed ID: 12526921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia.
    Loh ML; Silverman LB; Young ML; Neuberg D; Golub TR; Sallan SE; Gilliland DG
    Blood; 1998 Dec; 92(12):4792-7. PubMed ID: 9845546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the TEL-AML1 fusion gene in pediatric acute lymphoblastic leukemia in Turkey.
    Ozbek U; Sirma S; Agaoglu L; Yuksel L; Anak S; Yildiz I; Devecioglu O; Timur C; Meral A; Gedikoglu G
    J Pediatr Hematol Oncol; 2003 Mar; 25(3):204-8. PubMed ID: 12621238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia.
    Uckun FM; Pallisgaard N; Hokland P; Navara C; Narla R; Gaynon PS; Sather H; Heerema N
    Leuk Lymphoma; 2001 Jun; 42(1-2):41-56. PubMed ID: 11699220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
    Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
    Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia.
    de Haas V; Oosten L; Dee R; Verhagen OJ; Kroes W; van den Berg H; van der Schoot CE
    Br J Haematol; 2000 Dec; 111(4):1080-6. PubMed ID: 11167743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.